Introduction
As 2 O 3 induces clinical remission in acute promyelocytic leukemia (APL) patients (Shen et al., 1997; Soignet et al., 1998) . Several groups, including ours, have shown that low concentrations of As 2 O 3 selectively induce apoptosis in APL-derived NB4 cells. However, other leukemia cells are insensitive to low As 2 O 3 concentrations (1-2 mM), although they are responsive to higher concentrations (45 mM) Shao et al., 1998; Dai et al., 1999; Jing et al., 1999) . Mechanistic studies indicated that As 2 O 3 -induced apoptosis is mediated by free radical species in leukemia cells (Chen et al., 1998; Gurr et al., 1999; Jing et al., 1999) . In APL cells it was reported that As 2 O 3 induced H 2 O 2 accumulation, and that the ability of As 2 O 3 to induce apoptosis in these cells depends on the activity of the enzymes that regulate the cellular H 2 O 2 content. One of these enzymes is glutathione-Stransferase p (GSTp). NB4 cells have relatively low levels of GSTp . It has been suggested that GSTp plays an important role in the cellular efflux of As 2 O 3 by catalysing the conjugation of As 2 O 3 with reduced glutathione (GSH) since GSTp was found to be significantly increased in established arsenic-resistant or -tolerant cell lines (Lo et al., 1992; Liu et al., 2001 ). These observations lead to the expectation that cancer cells that do not express GSTp would be highly sensitive to As 2 O 3 .
Human prostate cancer tissue is characterized by a frequent loss of GSTp (Lee et al., 1994; Cookson et al., 1997; Moskaluk et al., 1997; Lin et al., 2001 ). This suggests that As 2 O 3 might be useful in the treatment of prostate cancer. However, we show here that GSTp expression positively correlates with cell sensitivity to As 2 O 3 -induced growth inhibition in three prostate cancer cell lines. Moreover, As 2 O 3 at low (therapeutic) concentrations does not induce apoptosis in any of the prostate cancer cell lines studied whether or not they expressed GSTp. LNCaP cells, which lack GSTp expression, are sensitive to As 2 O 3 -induced apoptosis at higher concentrations. Ectopic expression of GSTp in LNCaP cells decreases the ability of As 2 O 3 to induce apoptosis at higher concentrations, but increases the ability of As 2 O 3 to inhibit cell growth at therapeutic concentrations. We conclude that As 2 O 3 induces growth inhibition and apoptosis through different mechanisms in prostate cancer cells.
Results

DU-145 and PC-3 cells are more sensitive than LNCaP cells to As 2 O 3 -induced growth inhibition
The effects of As 2 O 3 on growth inhibition of three prostate cancer cell lines (DU145, PC-3 and LNCaP cells) were tested by MTT and colony-formation assays. As 2 O 3 inhibited cell growth in all three of the cell lines in a dose-dependent pattern as determined by MTT assay.
DU-145 cells were highly responsive to As 2 O 3 -mediated growth inhibition with an IC 50 of below 0.4 mM. PC-3 cells were also sensitive to As 2 O 3 with an IC 50 of about 1 mM. However, LNCaP cells were much less sensitive to As 2 O 3 with an IC 50 of 3.7 mM ( Figure 1a ). As 2 O 3 inhibited colony formation of both DU-145 and PC-3 cells at concentrations as low as 0.5 mM, but did not inhibit colony formation of LNCaP cells even at a concentration of 1.5 mM (Figure 1b and c) . These data indicate that prostate cancer cells vary in their sensitivity to As 2 O 3 .
As 2 O 3 at low concentrations does not induce apoptosis in the prostate cancer cells studied Treatment with 1-2 mM As 2 O 3 did not induce apoptosis in the three cell lines examined by TUNEL assay, although the proliferation of DU-145 cells and PC-3 cells was strongly inhibited by As 2 O 3 at these concentrations (Figures 1 and 2) . Consistent with TUNEL assay data, Western blot analysis showed that PARP protein was not cleaved in both DU-145 and LNCaP cells after treatment with 1-2 mM As 2 O 3 ( Figure 3 ).
As 2 O 3 at low concentrations inhibits cell growth by arresting cell in G2/M phase DU-145 cells expressed relative low levels of p21 and p27 proteins and As 2 O 3 slightly increased p21 protein in DU145 cells. Similarly, p21 but not p27 protein was slightly increased in LNCaP cells (Figure 3 ). Cell cycle analysis indicated that As 2 O 3 increased the number of cell in S and G2/M phases (DU-145 cells) or mainly in the G2/M phase (PC-3 cells), but As 2 O 3 did not change Since most solid tumors, unlike hemopoietic cells, were only sensitive to As 2 O 3 -induced apoptosis at concentrations higher than therapeutic doses (Bode and Dong, 2000) , the apoptotic effect of As 2 O 3 on the three prostate cancer cell lines was examined after 10-20 mM treatments by TUNEL assay. As shown in Figure 7a , As 2 O 3 induced apoptosis in LNCaP cells, but not in PC-3 and DU-145 cells at these concentrations. Moreover, As 2 O 3 induced 30% of LNCaP/pcDNA3.1 cells to undergo apoptosis, but less than 15% of LNCaP/ GSTp#10 cells underwent apoptosis after treatment with 20 mM As 2 O 3 ( Figure 7b ). These data suggest that GSTp inhibits As 2 O 3 -induced apoptosis even at higher As 2 O 3 concentrations.
As 2 O 3 activates ERK, p38 and JNK in LNCaP cells, but not in DU-145 and PC-3 cells As 2 O 3 at a concentration of 20 mM increased the levels of the phosphorylated forms of p-JNK, p-ERK1/2, and (Figure 8 ), but not at concentrations lower than 5 mM (data not shown). As 2 O 3 slightly increased p-p38 and p-JNK, but decreased p-ERK1/2 in DU-145 cells only at relatively higher concentrations. There were no significant changes in the phosphorylation of these kinases in PC-3 cells after As 2 O 3 treatment even with higher dose (Figure 8 ). As in parental LNCaP cells, the p-JNK, p-p38 and p-ERK1/2 were increased in LNCaP/pcDNA3.1 cells after treatment of 20 mM As 2 O 3 ( Figure 9 ). However, p-JNK was only slightly induced and p-p38 was not induced at all in LNCaP/GSTp#10 cells after As 2 O 3 treatment at a concentration of 20 mM ( Figure 9 ). Since p-ERK1/2 was still increased in LNCaP/ GSTp#10 cells as that in LNCaP/pcDNA3.1 cells after As 2 O 3 treatment (Figure 9 ), it appears that the inhibition of the activation of p-38 and JNK are responsible for GSTp effects on As 2 O 3 -induced apoptosis.
As 2 O 3 increases p53 protein in LNCaP cells at higher concentrations
To test whether p53 is involved in As 2 O 3 -induced apoptosis, p53 protein levels were determined after As 2 O 3 treatment. As 2 O 3 did not induce p53 protein or apoptosis in LNCaP cells at lower concentrations (Figures 2 and 3) . As 2 O 3 -induced apoptosis in LNCaP cells at higher concentrations ( Figure 7 ) correlated with the As 2 O 3 -induced elevation of p53 protein levels ( Figure 10 ). As 2 O 3 had no effect on p53 protein levels in DU-145 or PC-3 cells ( Figure 10 ). As 2 O 3 (10 mM) increased the p53 protein levels in LNCaP/pcDNA3.1 cells, but had a weak effect in LNCaP/GSTp cells.
Discussion
It has been suggested that GSTp plays an important role in the detoxification of As 2 O 3 (Wang and Lee, 1993; Wang et al., 1996; Liu et al., 2001) and several reports have shown that GSTp expression is strikingly increased in arsenic-resistant cell lines (Lo et al., 1992; Liu et al., 2001) . However, it has been shown that growth inhibition by arsenic is not correlated with GSTp (Yang et al., 1999) . Previously we found that NB4 cells, which have lower levels of GSTp, were more sensitive to As 2 O 3 -induced apoptosis than other leukemia cell lines . Thus, GSTp may function differently in As 2 O 3 -induced growth inhibition and apoptosis. As 2 O 3 treatment inhibited cell growth at 1 mM in DU-145 and PC-3 cells, but not in LNCaP cells (Figure 1 ). Since DU-145 and PC-3 cells, but not LNCaP cells, expressed GSTp mRNA and protein ( Figure 5 ), GSTp expression may enhance As 2 O 3 -mediated growth inhibition. To support this possibility, GSTp stably transfected LNCaP/GSTp cells had increased sensitivity to As 2 O 3 -growth inhibition ( Figure 6 ). Although DU-145 and PC-3 cells were highly sensitive to As 2 O 3 -mediated growth inhibition, apoptotic cells were not detected in any of the three tested cell lines after treatment with 1 or 2 mM As 2 O 3 by the most sensitive TUNEL assay (Figure 2 ). These data suggest that GSTp enhances As 2 O 3 -mediated cell growth inhibition through an apoptosis-independent pathway. Although p21 protein was increased in DU-145 cells by As 2 O 3 treatment, since it was also induced in LNCaP cells it does not necessarily contribute to As 2 O 3 -mediated growth inhibition ( Figure 3 ). As 2 O 3 treatment induced cell cycle arrest in G2/M phase in PC-3, DU-145 and LNCaP/GSTp cells, but not in LNCaP cells (Figures 4 and 6d ). These data, in agreement with other reports (Park et al., 2001; Huang et al., 2002) , indicate that As 2 O 3 inhibits cell growth in prostate cancer cells, at least in part, by targeting the cell cycle. Recently, it has been found that arsenic was methylated in vivo and in cultured cells, and that the methylated arsenic metabolites were more potent cytotoxic agents than inorganic arsenic (Styblo et al., 2000; Styblo et al., 2002; Chen et al., 2003) . It is possible that GSTp expression promotes arsenic methylation in prostate cancer cells and then in turn increases the cell sensitivity to As 2 O 3 . This hypothesis needs to be studied further. In contrast to the effects of low concentrations of As 2 O 3 on cell growth inhibition, LNCaP cells, but not DU-145 and PC-3 cells, underwent apoptosis when treated by high (410 mM) As 2 O 3 concentrations. These data suggest that As 2 O 3 induces apoptosis through a pathway different from that leading to growth inhibition. Therefore, MAP kinase pathways, which have been found to be activated by arsenic in apoptotic cells at (Liu et al., 1996; Ludwig et al., 1998; Samet et al., 1998; Huang et al., 1999; Bode and Dong, 2000; Iwama et al., 2001) , were studied. Consistent with these reports, ERK, JNK and p38 kinases were activated by 10 mM As 2 O 3 treatment in LNCaP cells, but not in PC-3 and DU-145 cells (Figure 8 ). GSTp was recently reported to inhibit JNK activity by protein-protein interaction (Adler et al., 1999; Yin et al., 2000; Wang et al., 2001) . DU-145 and PC-3 cells expressed GSTp ( Figure 5 ) and were not sensitive to As 2 O 3 -induced apoptosis after 10 mM As 2 O 3 treatment (Figure 7 ). These findings suggest that GSTp indeed has an inhibitory effect on As 2 O 3 -induced apoptosis at this higher concentration. In support of this hypothesis, LNCaP/GSTp cells became less sensitive to As 2 O 3 -induced apoptosis than empty vectortransfected cells (Figure 7) . Moreover, JNK activation by As 2 O 3 was inhibited in LNCaP/GSTp cells (Figure 9) . Similarly, p38 kinase activation, but not ERK1/2 activation, was also inhibited in LNCaP/GSTp cells (Figure 9 ). Thus, our data indicate that GSTp acts as an inhibitor of As 2 O 3 -induced apoptosis, at least in part, by inhibiting both JNK and p38 kinase activation. Since GSTp transfection only partly inhibited As 2 O 3 -induced apoptosis in LNCaP/GSTp cells (Figure 7 ), other factors in addition to GSTp may also account for the differential sensitivity of LNCaP cells comparing to that It is well known that p53 protein mediates apoptosis induction due to many chemotherapeutic agents (Blagosklonny, 2002) . LNCaP cells contain wild-type p53 and both DU-145 and PC-3 contain mutant p53 (Polek et al., 2003) . It was found that p53 protein was induced by As 2 O 3 in LNCaP cells, which correlated with apoptosis induction (Figures 7 and 10) . However, p53 induction was not completely inhibited in LNCaP/GSTp cells ( Figure 10 ) and a partial apoptotic response was still observed after As 2 O 3 treatment (Figure 7 ), suggesting that p53 contributes to As 2 O 3 -induced apoptosis in LNCaP cells. On the basis of these results, we conclude that (1) GSTp enhances As 2 O 3 -mediated growth inhibition by arresting prostatic cancer cells in G2/M phase at low concentrations; (2) GSTp blocks As 2 O 3 -induced apoptosis in these cells by inhibiting JNK and p38 kinase activation at higher concentrations and (3) since As 2 O 3 inhibits cell growth, but did not induce apoptosis at therapeutic concentrations (1-2 mM) and since GSTp expression enhanced As 2 O 3 -mediated growth inhibition, GSTp should be considered as a favorable target in the possible development of As 2 O 3 as an agent to be used in the treatment of prostate cancer.
Materials and methods
Cell lines
DU-145, PC-3 and LNCaP cells were obtained from the American Type Culture Collection (Rockville, MD, USA) and were cultured in RPMI-1640 medium supplemented with 100 U/ml penicillin, 100 mg/ml streptomycin, 1 mM L-glutamine and 10% heat-inactivated fetal bovine serum.
MTT assay
Cells (2 Â 10 3 ) were plated in each well of a 96-well plate and were allowed to adhere and spread for 24 h. The various concentrations of As 2 O 3 to be tested were then added and cultured for 4 days at 371C. In total, 50 ml of 2 mg/ml MTT solution was added per well and the cultures were continued for an additional 4 h. The medium was removed by aspiration. The cells were dissolved in 200 ml DMSO, and absorbance at 570 nm was measured in the 96-well plate. Growth inhibition was determined as compared to untreated cells (%).
Colony assays
Approximately 10 3 cells were plated for 18-24 h prior to treatment in six-well plates. Approximately 24 h later, medium was changed with the indicated concentrations of As 2 O 3 cells and the medium was changed every 2-3 days. The cells were stained with methylene blue (0.1% in methanol) after 12-14 days treatment. Visible colonies (450 cells) were counted and percent colony suppression was calculated by dividing the number of colonies for each treatment by control and multiplying that number by 100 Leszczyniecka et al., 2002) .
Quantity of apoptotic cells
DNA fragmentation was estimated by labeling DNA strand breaks with terminal deoxynucleotidyl transferase (TUNEL assay) . TUNEL assay was performed according to the manufacturer's instructions (PharMingen). Cells were analysed by flow cytometry using a FACScan. All data were collected, stored and analysed by LYSIS II software (Becton Dickinson).
Analysis of cell cycle progression
The cells treated with As 2 O 3 were harvested by trypsinization and washed with PBS. Then the cells were fixed in cold (À701C) 70% ethanol at a density of 1 Â 10 6 /ml for 1 h. The cells were spun at 2000 r.p.m. at 41C for 5 min and washed with cold PBS twice; the pellet was resuspended in 500 ml of PBS containing 100 mg/ml RNase and 50 mg/ml propidium iodide (PI), and incubated at room temperature for 30 min. The cell cycle was analysed by FACscan.
Western blot analysis
Protein extracts (50 mg) prepared with RIPA lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 0.1%. SDS, 1% NP-40, 0.5% sodium deoxycholate, 1 mM PMSF, 100 mM leupeptin and 2 mg/ml aprotinin, pH 8.0) were separated on an 8 or 12% SDS-polyacrylamide gel, and then transferred to nitrocellulose membranes. The membranes were stained with 0.2% Ponceau S red to assure equal protein loading and transfer. After blocking with 5% nonfat milk, the membranes were incubated with polyclonal antibody to PARP (Boehringer Mannheim, Indianapolis, IN, USA), GSTp (Calbiochem, La Jolla, CA, USA), antibodies to p21 and p27 (Santa Cruz, CA, USA), antibodies to phosphoSAPK/JNK, phospho-ERK1/2 and phospho-p38 (Signal Transduction Lab). Immunocomplexes were visualized by chemiluminescence (ECL kit, Amersham) .
Northern blot analysis
Total RNA was isolated with PURESCRIPT (Gentra Systems) from 10 6 cells. RNA (20 mg) was size fractionated on a 1.2% agarose-2.2 M formladehyde gel, transferred to hybrid-N þ membrane (Amersham) in 20 Â SSC, and UVcrosslinked (Stratalinker). GSTp cDNA was obtained from 
